Subscribe
shutterstock_1650524983_sundry_photography
Sundry Photography / Shutterstock.com
21 February 2020AmericasSarah Morgan

Illumina asks court to halt BGI’s sequencer distribution

Genetic sequencing company Illumina is seeking a preliminary injunction to stop its China-based rival BGI from distributing DNA sequencers in the US.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Illumina secures injunction against BGI
18 June 2020   Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
Big Pharma
BGI counter sues Illumina for patent infringement
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
Illumina accuses BGI of patent infringement, again
2 July 2019   Genetic sequencing company Illumina has continued its campaign of filing patent lawsuits against rival BGI, with the filing of three additional infringement suits.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Americas
Illumina secures injunction against BGI
18 June 2020   Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
Big Pharma
BGI counter sues Illumina for patent infringement
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
Illumina accuses BGI of patent infringement, again
2 July 2019   Genetic sequencing company Illumina has continued its campaign of filing patent lawsuits against rival BGI, with the filing of three additional infringement suits.

More on this story

Americas
Illumina secures injunction against BGI
18 June 2020   Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
Big Pharma
BGI counter sues Illumina for patent infringement
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
Illumina accuses BGI of patent infringement, again
2 July 2019   Genetic sequencing company Illumina has continued its campaign of filing patent lawsuits against rival BGI, with the filing of three additional infringement suits.

More features

WATCH: The transparency tightrope—balancing innovation, regulation, and IP protection in a new era
Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
Powell Gilbert launches Düsseldorf office with leading patent litigator
Startups toolkit: Why investors want more than patents
J&J fends off generic schizophrenia drug bids
Kilpatrick adds ‘seasoned litigator’ as trademark partner
WATCH: An update on EPO Board of Appeal strategy for 2025 and beyond
Startup challenges rival over brain monitoring tech at ITC